Intuitive Surgical, Inc. $ISRG Shares Acquired by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the 3rd quarter, Holdings Channel.com reports. The fund owned 54,958 shares of the medical equipment provider’s stock after acquiring an additional 1,650 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Intuitive Surgical were worth $24,579,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Rossmore Private Capital lifted its position in shares of Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares in the last quarter. Activest Wealth Management increased its stake in Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after buying an additional 20 shares during the period. Vertex Planning Partners LLC increased its stake in Intuitive Surgical by 2.3% during the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after buying an additional 21 shares during the period. Accredited Investors Inc. lifted its holdings in Intuitive Surgical by 2.0% during the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after buying an additional 21 shares in the last quarter. Finally, SPC Financial Inc. boosted its position in Intuitive Surgical by 1.3% in the 3rd quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock valued at $722,000 after buying an additional 21 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 750 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the completion of the transaction, the director directly owned 15,720 shares in the company, valued at $8,355,494.40. The trade was a 15.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 70,011 shares of company stock worth $38,858,275. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 2.5%

Shares of NASDAQ:ISRG opened at $488.15 on Monday. The firm has a 50 day simple moving average of $549.63 and a 200-day simple moving average of $510.60. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08. The company has a market capitalization of $173.36 billion, a PE ratio of 61.87, a P/E/G ratio of 3.79 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ISRG shares. Evercore cut their price objective on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. Rothschild & Co Redburn boosted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Citigroup reiterated a “neutral” rating and issued a $590.00 price objective (down previously from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $617.23.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.